Nivolumab,Ipilimumab
BMS
['niche2']
new data on immunotherapy for stage iii colon cancer msi-h and appear again at #esmo22 with large sample size pcr 95%!! #niche2 waiting for the 3-years dfs 2023 
Oncology/Hematology Clinical Pharmacist | ???? ????